Tang Xin, Tian Jiaxin, Xie Liping, Ji Yong
Key Laboratory of Cardiovascular and Cerebrovascular Medicine, Key Laboratory of Targeted Intervention and Cardiovascular Disease, Collaborative InnovationCenter for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
J Biomed Res. 2019 Jul 30;0(0):1-9. doi: 10.7555/JBR.33.20190070.
Cardiac fibrosis is a common pathological change of many cardiovascular diseases. β-catenin has been shown to promote fibrosis. However, the precise role of its homolog γ-catenin in the process of fibrosis remains largely unclear. In this study, we found that the expression of γ-catenin was significantly decreased in angiotensin Ⅱ (Ang Ⅱ)-induced cardiac fibrosis model, contrary to most reports of β-catenin. Overexpression of γ-catenin in cardiac fibroblasts (CFs) significantly inhibited the expression of α-smooth muscle actin (α-SMA), whereas knocking down the expression of γ-catenin with siRNA promoted the occurrence of cardiac fibrosis. Mechanistically, γ-catenin could bind to GSK-3β to inhibit the phosphorylation of GSK-3β, therefore preventing cardiac fibrosis. Our study shows that γ-catenin is an important protective factor in cardiac fibrosis, which provides a new potential target for the treatment of cardiac fibrosis.
心脏纤维化是许多心血管疾病常见的病理变化。β-连环蛋白已被证明可促进纤维化。然而,其同源物γ-连环蛋白在纤维化过程中的具体作用仍不清楚。在本研究中,我们发现与大多数β-连环蛋白的报道相反,在血管紧张素Ⅱ(AngⅡ)诱导的心脏纤维化模型中,γ-连环蛋白的表达显著降低。在心脏成纤维细胞(CFs)中过表达γ-连环蛋白可显著抑制α-平滑肌肌动蛋白(α-SMA)的表达,而用小干扰RNA(siRNA)敲低γ-连环蛋白的表达则促进心脏纤维化的发生。机制上,γ-连环蛋白可与糖原合成酶激酶-3β(GSK-3β)结合,抑制GSK-3β的磷酸化,从而预防心脏纤维化。我们的研究表明,γ-连环蛋白是心脏纤维化中的一个重要保护因子,为心脏纤维化的治疗提供了一个新的潜在靶点。